Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Pfizer Inc. company officials threatened legal action against two former top executives who had been working with Starboard ...
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...
Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer (NYSE: PFE) ...
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
Key Takeaways Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback